Federal contract

CVS Health (CVS)VA awarded $204K

VA awarded CVS Health a contract with $204K committed so far.

$204K
committed so far
Signed
Apr 1, 2026
Updated
Aug 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 21, 2025CongressDisclosed partial sale of CVS — reported range $1,001 - $15,000
  2. Jan 29, 2026CongressDisclosed purchase of CVS — reported range $1,001 - $15,000
  3. Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
  4. Mar 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 18, 2026, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected John E. Gallina to serve on the Board, effective March 19, 2026.”
  5. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  6. Mar 27, 2026CongressDisclosed purchase of CVS — reported range $1,001 - $15,000
  7. Mar 31, 2026Government · Federal Register proposed ruleFiduciary Duties in Selecting Designated Investment Alternatives

What came next

  1. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  2. May 6, 2026Company filing · Form 8-K · ResultsReported its results
  3. May 8, 2026Insider · 6 days before an 8-KOfficer sold ~$6.23M of CVS shares in the open market
  4. May 14, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 14, 2026, CVS Health Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the 2026 Incentive Compensation Plan of CVS Health Corporation (the “2026 ICP”), which replaces the Company’s expiring 2017 Incentive Compensation Plan.”
  5. May 19, 2026Insider · 1 personInsiders: 2 sales (~$187.3M)
  6. May 20, 2026Insider · 1 personInsiders: 4 sales (~$95.5M)
  7. May 21, 2026Insider · 1 personInsiders: 2 sales (~$69.9M)
View the official recordUSAspending.gov award record

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for CVS Health

For CVS Health, OQRO holds 1 Congress trade report, 46 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CVS page.

How this filing works

Other disclosures at CVS Health

Everything OQRO holds on this company is on its CVS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data